Current Therapeutic Strategies for Patients With Polyneuropathies Secondary to Inherited Metabolic Disorders

Burns, Ted M.; Ryan, Monique M.; Darras, Basil; Jones Jr., H. Royden
July 2003
Mayo Clinic Proceedings;Jul2003, Vol. 78 Issue 7, p858
Academic Journal
Supportive care, symptomatic treatment, and patient education should be provided for patients with inherited or acquired polyneuropathies. In addition, specific treatment is available for many of the acquired polyneuropathies. Genetic counseling is valuable for many patients with inherited polyneuropathies, but only rarely is specific treatment an option for these patients. However, specific treatments are available for many of the rare and devastating systemic disorders associated with polyneuropathies. Thus, clinicians must promptly diagnose these inherited disorders so that specific treatment may be initiated. The clinical features of these rare inherited disorders are emphasized.


Related Articles

  • Repurposing Diflunisal for Familial Amyloid Polyneuropathy. Berk, John L.; Suhr, Ole B.; Obici, Laura; Yoshiki Sekijima; Zeldenrust, Steven R.; Taro Yamashita; Heneghan, Michael A.; Gorevic, Peter D.; Litchy, William J.; Wiesman, Janice F.; Nordh, Erik; Corato, Manuel; Lozza, Alessandro; Cortese, Andrea; Robinson-Papp, Jessica; Colton, Theodore; Rybin, Denis V.; Bisbee, Alice B.; Yukio Ando; Shu-ichi Ikeda // JAMA: Journal of the American Medical Association;12/25/2013, Vol. 310 Issue 24, p2658 

    IMPORTANCE Familial amyloid polyneuropathy, a lethal genetic disease caused by aggregation of variant transthyretin, induces progressive peripheral nerve deficits and disability. Diflunisal, a nonsteroidal anti-inflammatory agent, stabilizes transthyretin tetramers and prevents amyloid fibril...

  • Two siblings with triple A syndrome and novel mutation presenting as hereditary polyneuropathy. Dumic, Miroslav; Barišić, Nina; Rojnić-Putarek, Nataša; Stanimirović, Andrija; Koehler, Katrin; Huebner, Angela; Kušec, Vesna // European Journal of Pediatrics;Mar2011, Vol. 170 Issue 3, p393 

    The clinical and molecular data on triple A syndrome in two siblings (girl 3.5 years and boy 5.5 years at presentation) with early onset of neurological dysfunction are described. Both patients showed delayed developmental milestones and neurological dysfunctions (motor and sensory demyelinating...

  • Diagnosis and Treatment of Hereditary Spastic Paraplegia and Genomic Typing. YU Wen-qian; DUAN Wen-yuan; JU Ji-feng; WANG Tong-jian; ZHU Meng; HUANG Jing // Journal of International Reproductive Health/Family Planning;May2014, Vol. 33 Issue 3, p191 

    Hereditary spastic paraplegia (HSP) is a group of neurodegenerative disorders with clinical and genetic heterogeneity. The main clinical feature is the progressive spasticity of lower limbs and myasthenia. HSPs are clinically divided into types: simple type and complicated form, the later with...

  • Hereditary neuropathy with liability to pressure palsies and amyotrophic lateral sclerosis. Bhatt, Archit; Farooq, Muhammad U.; Aburashed, Rany; Kassab, Mounzer Y.; Majid, Arshad; Bhatt, Shaila; Naravetla, Bharath; Dhaliwal, Gurmail // Neurological Sciences;Jun2009, Vol. 30 Issue 3, p241 

    A 56-year-old male with recurrent painless focal neuropathies and a family history of peripheral neuropathy of unknown etiology presented with progressively worsening of impaired sensations and weakness in his lower extremities. His initial electrodiagnostic evaluation was suggestive of severe...

  • Keratoderma. Gladis, Becky L. // Dermatology Nursing;Apr2005, Vol. 17 Issue 2, p145 

    This article discusses various issues related to keratoderma. Keratoderma is an inherited genetic disorder. It can occur in the first few months of life and almost always presents by age 3. Clinically there is a bilateral yellow thickening of the skin. This thickening varies greatly from rough...

  • Spotlight focuses on protein-misfolding therapies. Ratner, Mark // Nature Biotechnology;Oct2009, Vol. 27 Issue 10, p874 

    The article focuses on a study which examined the effectiveness of tafamidis meglumine (FX-1006A) in modifying disease progression in patients diagnosed with rare inherited protein-misfolding neuropathy. The study included 128 patients diagnosed with genetic disorder transthyretin (TTR) amyloid...

  • A family with heredopathia atactica polyneuritiformis (Refsum's disease). Britton, T. C.; Gibberd, F. B. // Journal of the Royal Society of Medicine;Oct1988, Vol. 81 Issue 10, p602 

    The article presents a case report of a family with heredopathia atactica polyneuritiformis (HAP). This disease is a rare autosomal recessive disorder characterized by retinitis pigmentosa, ataxia and polyneuropathy. All the six children are affected by the disease. The authors emphasize the...

  • Update in the diagnosis and management of transthyretin familial amyloid polyneuropathy. Plante-Bordeneuve, Violaine // Journal of Neurology;Jun2014, Vol. 261 Issue 6, p1227 

    Transthyretin familial amyloid polyneuropathy (TTR-FAP) is a progressive neurodegenerative and systemic genetic disease first identified in Portugal, now reported worldwide. During the past few years our knowledge on the phenotypic presentation of this devastating condition has remarkably...

  • Novel splice site mutation of SPG4 in a Chinese family with hereditary spastic paraplegia. Liu, Xiaomin; Tang, Jiyou // Neurological Sciences;Sep2014, Vol. 35 Issue 9, p1453 

    No abstract available.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics